IP Library Granted Patent US 8,840,927
Granted Patent B2
US 8,840,927 · App. 10/468,438 · Granted Sep 23, 2014

Method of making anti-microbial polymeric surfaces

Inventors: Valerio DiTizio (Toronto, CA); Frank DiCosmo (Richmond Hill, CA)
Assignee: Covalon Technologies Inc.
A61L31/10A61L29/16A61L27/54A61L27/34A61L2300/606A61L31/16A61L29/085A61L2300/104A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,840,927
App. No.
10/468,438
Granted
Sep 23, 2014
Kind
B2
Abstract

The present invention is a method for the modification of the surfaces of polymeric materials with polymer coatings that may be subsequently treated to be lubricious and anti-microbial. The method comprises incubating a photo-initiator-coated polymeric material with an aqueous monomer that is capable of free radical polymerization and exposing the incubating polymeric material to UV light creating a modified surface on said polymeric material. The method may additionally comprise adding a silver component to the modified surface. The silver component may be provided as a silver salt coating or a silver salt contained within a hydrogel bonded to the acrylate modified polymeric material surface.

Claims (20)

1. An anti-microbial polymeric composite comprising:

a polymeric body made of a polymeric material selected from the group consisting of polyurethanes, polyamides, polyesters, polyethers, polyorganosiloxanes, polysulfones, polytetrafluoroethylene and polysiloxanes, said polymeric body having a stable hydrophilic polyacrylate coating permanently grafted to the surface of the polymeric body, said coating being ionized and then cation saturated to render it lubricious, and said coating having a silver agent that is released from said polyacrylate coating slowly and continuously for a long and effective period of time.

2. The polymeric composite of claim 1 , wherein said polymeric material is polysiloxane and said polysiloxane is silicone.

3. The polymeric composite of claim 2 , wherein said polymeric material is provided as a device selected from the group consisting of implants, catheters, stents, wound dressings, cardiac valves, tubings, pins and clips.

4. The polymeric composite of claim 3 , wherein said silver agent comprises a silver salt selected from the group consisting of silver lactate, silver phosphate, silver citrate, silver acetate, silver benzoate, silver chloride, silver carbonate, silver iodide, silver iodate, silver nitrate, silver laurate, silver sulfadiazine, silver palmitate and mixtures thereof.

5. The polymeric composite of claim 4 , wherein said stable polyacrylate coating is made by the free radical polymerization of a monomer selected from the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylate, 4-vinylbenzoic acid, itaconic acid, and mixtures thereof.

6. An anti-microbial polymeric composite comprising:

a polymeric body made of a polymeric material of silicone, said polymeric body having a stable hydrophilic polyacrylate coating permanently grafted to the surface of the polymeric body, said coating being ionized and then cation saturated to render it lubricious, and said coating having a silver agent that comprises a silver salt selected from the group consisting of silver lactate, silver phosphate, silver citrate, silver acetate, silver benzoate, silver chloride, silver carbonate, silver iodide, silver iodate, silver nitrate, silver laurate, silver sulfadiazine, silver palmitate and mixtures thereof.

7. An anti-microbial polymeric composite comprising:

a polymeric body made of a polymeric material selected from the group consisting of polyurethanes, polyamides, polyesters, polyethers, polyorganosiloxanes, polysulfones, polytetrafluoroethylene and polysiloxanes,

said polymeric body is provided as a device selected from the group consisting of implants, catheters, stents, wound dressings, cardiac valves, tubings, pins and clips,

said polymeric body having a stable hydrophilic polyacrylate coating permanently grafted to the surface of the polymeric body, said coating being ionized and then cation saturated to render it lubricious, and said coating having a silver agent that comprises a silver salt selected from the group consisting of silver lactate, silver phosphate, silver citrate, silver acetate, silver benzoate, silver chloride, silver carbonate, silver iodide, silver iodate, silver nitrate, silver laurate, silver sulfadiazine, silver palmitate and mixtures thereof.

8. The composite of claim 7 , wherein said stable polyacrylate coating is made by the free radical polymerization of a monomer selected from the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylate, 4-vinylbenzoic acid, itaconic acid, and mixtures thereof.

9. The composite of claim 6 or 7 , wherein said lubricious coating is maintained when said composite is clinically used in vivo.

10. The composite of claim 1 , wherein said coating is ionized using an aqueous base solution.

11. The composite of claim 10 , wherein said cations are provided by a solution selected from the group consisting of sodium lactate, sodium citrate, disodium phosphate, potassium lactate, potassium citrate, dipotassium phosphate and mixtures thereof.

12. The composite of claim 1 , wherein said lubricious coating is maintained when said composite is clinically used in vivo.

13. The composite of claim 2 , wherein said silicone is silicone rubber.

14. The composite of claim 6 , wherein said silicone is silicone rubber.

15. The composite of claim 7 , wherein said wherein said polymeric material is polysiloxane and said polysiloxane is silicone rubber.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2021
From: HSBC BANK CANADA
To: COVALON TECHNOLOGIES INC.
Reel/Frame 057039/0414 →
SECURITY INTEREST Recorded Aug 13, 2018
From: COVALON TECHNOLOGIES INC.
To: HSBC BANK CANADA
Reel/Frame 046627/0692 →
CHANGE OF NAME Recorded Mar 9, 2005
From: UROTEQ INC.
To: COVALON TECHNOLOGIES INC.
Reel/Frame 015861/0378 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2003
From: DITIZIO, VALERIO; DICOSMO, FRANK
To: UROTEQ, INC.
Reel/Frame 014751/0736 →
Continuity (2)
Provisional Application 60271702 · Feb 28, 2001
Related Publication 20040086568A1 · May 6, 2004